OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production employs Chinese hamster ovary (CHO) cells due to their adaptability in expressing complex biologics. Optimizing these processes involves modifying various variables, including cell line development, media composition, and bioreactor settings. A key goal is to increase antibody yield while reducing production financia